Adel Mustafa is Professor in the Department of Radiology and Biomedical Imaging at Yale School of Medicine. He serves as Director of the Yale Diagnostic Medical Physics Residency Program and Chief of Diagnostic Radiology Physics at Yale New Haven Health System. His work integrates clinical service, education, and research in medical physics. His primary research interests are in image quality optimization , radiation dose management , and the quantification of disease conditions using multiple imaging modalities, with a particular focus on CT imaging. He leads a multidisciplinary team of medical physicists and collaborates with radiologists and clinicians to advance detection, quantification, and optimization in CT. Dr. Mustafa is board certified by the American Board of Radiology (ABR) and the American Board of Medical Physics (ABMP) in diagnostic imaging physics. He is an elected Fellow of the American Association of Physicists in Medicine (AAPM), recognizing his contributions to the field. Fellow of the American Association of Physicists in Medicine (2007) He plays a significant national and international leadership role in medical physics, having served on numerous AAPM committees and as an examiner for the ABR since 2004. Currently, he is Chairman of the Accreditation Committee and Chief Examiner for the International Medical Physics Certification Board (IMPCB), shaping standards and certification globally. He established the Yale Diagnostic Medical Physics Residency under GMEC and continues to lead it as Program Director. Dr. Mustafa's team focuses on advancing clinical imaging through physics-driven innovation, with an emphasis on safety, accuracy, and quantitative analysis in diagnostic radiology.
Polina Golland is a Professor in the Department of Electrical Engineering and Computer Science (EECS) at MIT and a Principal Investigator in the Computer Science and Artificial Intelligence Laboratory (CSAIL). Her research focuses on developing novel techniques for biomedical image analysis and understanding, particularly in medical vision, AI/ML, and health care applications. She leads the Medical Vision Group and collaborates with the Vision Group at CSAIL. Her work emphasizes statistical modeling of medical images, shape modeling, and predictive analytics for biological processes. Current projects include fetal MRI analysis, cardiac MRI segmentation, and quantitative assessment of pulmonary edema in chest X-rays. She has secured grants from NIH, MIT-IBM Watson AI Lab, and other institutions to support her research. Dr. Golland teaches courses on inference, probability, and probabilistic systems. She advises graduate students in MIT's EECS program and has mentored numerous postdocs and researchers. Her lab focuses on translating advanced imaging techniques into clinical workflows, with applications in neuroimaging, fetal health monitoring, and cardiovascular disease analysis. Notable collaborations include work with Harvard Medical School affiliates, Brigham and Women's Hospital, and the MIT Jameel Clinic. Her research aims to bridge computational methods with clinical needs, improving diagnostic tools and treatment planning through machine learning and medical imaging innovation.
Robert Rohling is a Professor at the University of British Columbia's Faculty of Applied Science, affiliated with the Department of Mechanical Engineering and holding a joint appointment with the Department of Electrical and Computer Engineering. As Director of the Institute of Computing, Information and Cognitive Systems (ICICS), his research focuses on biomedical engineering, medical imaging, robotics, and computational methods. B.A.Sc. (UBC) M.Eng. (McGill) Ph.D. (Cambridge) Rohling's work spans three primary research areas: medical imaging (3D ultrasound, spatial compounding, elasticity reconstruction), medical information systems (radiologist navigation tools for large image datasets), and robotic calibration for surgical applications. His multidisciplinary approach integrates mechanical and electrical engineering principles with clinical needs. Rohling's publications (2020-2022) reveal trends in advanced ultrasound techniques (e.g., shear wave vibro-elastography), AI-driven image processing (cycleGAN translation), and computational optimization for diagnostic accuracy. Keywords across his work include Medical Imaging, Biomedical Engineering, Robotics, and Computational Modeling. As director of the Robotics and Control Laboratory , Rohling leads interdisciplinary collaborations with industry and clinical partners to address practical challenges in medical diagnostics and surgical robotics. His research emphasizes translating engineering innovations into clinical practice.
Prof. Marcy Zenobi-Wong is a Full Professor at ETH Zurich's Department of Health Sciences and Technology, specializing in biofabrication and tissue engineering. Her research focuses on cartilage regeneration using advanced biomaterials, including nanofilm coatings and 3D printing techniques. She holds patents in tissue engineering and has pioneered methods like filamented light (FLight) biofabrication for creating anisotropic tissues. Her academic journey includes a B.Sc. from MIT (1985), M.Sc. and Ph.D. from Stanford (1987, 1990), followed by postdoctoral work at the University of Michigan. She leads the Biofabrication Group at ETH, developing therapies for joint repair and regenerative medicine. Courses taught include Biomedical Engineering and Materials and Mechanics in Medicine . Research highlights include engineered hydrogels for cartilage protection, CRISPR-driven gene editing in chondrocytes, and biohybrid neural interfaces. Her work bridges material science, cell biology, and clinical applications, with a focus on translational medicine. Collaborative projects involve creating elastic cartilage grafts for microtia reconstruction and volumetric printing of complex tissue constructs.
Martin T. Wells is the Charles A. Alexander Professor of Statistical Sciences at Cornell University, with joint appointments in the Department of Statistical Science, Department of Biological Statistics and Computational Biology, Department of Social Statistics, and as Professor of Clinical Epidemiology and Health Services Research at Weill Medical School. He serves as Editor-in-Chief of the ASA-SIAM Book Series and Co-Editor of the Journal of Empirical Legal Studies. Cornell University, Ithaca, NY Weill Cornell Medical College Research Interests span applied and theoretical statistics, Bayesian methods, biostatistics, clinical epidemiology, and computational biology. His work bridges disciplines like finance, legal studies, and health services research. Article Trends highlight advancements in Bayesian modeling, quantum cognition machine learning, tensor analysis, and misclassification correction, with applications in genomics, finance, and public health. Fellow of the American Statistical Association Fellow of the Royal Statistical Society Contributions include developing statistical software (e.g., rTensor), methodological innovations in clinical trials, and empirical legal studies on civil rights and the death penalty.
Professor Nancy W. Y. Law is a leading scholar in Learning Sciences and Technology at the University of Hong Kong's Faculty of Education . She has served as Founding Director of the Centre for Information Technology in Education (CITE) (1998-2013) and currently holds the Chair of Learning Sciences and Technology . Her career spans over 25 years of international comparative studies, policy analysis, and large-scale educational innovation. Current roles: Associate Dean (Strategic Development), HKU Key affiliations: Sciences of Learning Strategic Research Theme (co-convener) Research Expertise Her work focuses on technology-enhanced learning , digital literacy , knowledge building communities , and multilevel educational change . She pioneered network models of teacher innovation and socio-technical frameworks for sustainable pedagogical transformation, particularly in STEM education and Cyberbullying prevention . Scientific Leadership With over 25 major research grants (2000-2023) exceeding HK$50 million, she leads projects like: Learning and Assessment for Digital Citizenship Jockey Club Self-directed Learning in STEM Design-Aware Learning Analytics A Fellow of the International Society of Learning Sciences and recipient of the HKSAR Humanities and Social Sciences Prestigious Fellowship , she has supervised numerous international comparative studies including SITES 2006, ICILS 2013, and longitudinal digital citizenship research (2019-2021).
Laura Elo serves as Professor of Computational Medicine and Head of the Medical Bioinformatics Centre at the University of Turku, Finland. She concurrently holds the position of Research Director at Turku Bioscience Centre and acts as InFLAMES Flagship Contact, driving interdisciplinary biomedical research initiatives. Her academic foundation includes a PhD in Applied Mathematics (2007) and Adjunct Professorship in Biomathematics (2011), establishing her quantitative expertise before transitioning into biomedical applications. Her research program focuses on transforming molecular and clinical datasets through statistical modeling and advanced machine learning . Key thrusts include robust computational tools for proteome/epigenome analysis, AI-driven digital health diagnostics, and computational systems immunology for immune-mediated diseases. This work directly addresses challenges in reproducibility and scalability of high-throughput biotechnology data. Analysis of her recent publications reveals dominant themes in type 1 diabetes biomarker discovery , multi-omics integration , and immune system modeling , with strong emphasis on clinical translation through collaborations with experimental and medical teams. Her scientific recognition includes: JDRF Career Development Award Professor Elo actively trains MSc/PhD students and postdoctoral fellows while leading major research initiatives including ERC grants. Her teaching portfolio spans Bioinformatics Journal Club, AI in Diagnostics, and Systems Biology courses. The Elo Lab (https://elolab.utu.fi) operates as a hub for computational biomedicine, developing open-source tools like CellRomeR while maintaining close ties with Turku Bioscience Centre's experimental facilities for validating computational predictions in immunology and metabolic disease contexts.
David Erickson is the SC Thomas Sze Director and Sibley College Professor at Cornell University's Sibley School of Mechanical and Aerospace Engineering. He also holds a joint professorship in the Division of Nutritional Sciences. His research focuses on global health technologies, medical diagnostics, microfluidics, photonics, nanotechnology, and energy systems. He previously served as Associate Dean of Engineering for Research and Graduate Programs. Erickson leads the NIH-funded PORTENT Center for Point-of-Care Technologies in Global Health and has co-founded companies like Dimensional Energy and VitaScan to commercialize diagnostic and energy technologies. Education: B.Sc., Mechanical Engineering, University of Alberta (1999) M.A.Sc., Mechanical Engineering, University of Toronto (2001) Ph.D., Mechanical Engineering, University of Toronto (2004) Postdoctoral Scholar, Electrical Engineering, California Institute of Technology (2005) Research Interests: Erickson’s work spans global health diagnostics , nanobio applications , and clean energy innovation . He develops portable medical devices for low-resource settings, including smartphone-integrated diagnostic tools for malaria, iron deficiency, and cancer. His lab also pioneers photothermal reactors for CO2 conversion into sustainable fuels. Key areas include: Point-of-care testing for infectious diseases and nutritional deficiencies Nanofluidic and optofluidic technologies for biomolecular analysis Solar-driven energy systems for carbon-neutral fuels Awards: Presidential Early Career Award for Scientists and Engineers (2011) Fellowships from the Optical Society, ASME, and Canadian Academy of Engineering Carbon X-Prize Finalist (2019) for Dimensional Energy’s CO2-to-fuel technology Grants & Industry Collaboration: Erickson’s research is funded by NIH, NSF, ARPA-E, DOE, and USAID. His lab’s innovations have spun off start-ups addressing global health and energy challenges. Notable projects include: - Portable cancer diagnostics in sub-Saharan Africa using mobile phone-based systems - Solar-powered CO2 conversion reactors tested in Wyoming and Arizona Labs & Teams: The Erickson Lab collaborates with the Cornell Atkinson Center for Sustainability and the McGovern Center for Entrepreneurship. Key initiatives include the PORTENT Center and the Dimensional Energy CO2-to-fuel project.
Dr. Daniel Dutton is an Associate Professor in the Department of Community Health and Epidemiology at Dalhousie University's Faculty of Medicine, based at the Dalhousie Medicine New Brunswick campus in Saint John. His research focuses on how social environments influence health outcomes and the role of government policies in mitigating these impacts, particularly in areas like poverty, homelessness, and health economics. He holds adjunct roles at the University of New Brunswick (Sociology) and is the Scientific Director of APPTA, a hub bridging aging research and policy. He teaches courses in epidemiology, population health, and statistics. Education: PhD in Community Health Sciences (University of Calgary) MA in Economics (University of Calgary) BA Honours in Economics (Queen’s University) Research Interests: Dr. Dutton examines population-level health determinants, government policy effectiveness, and socioeconomic disparities. His work employs large datasets and econometric models to analyze topics such as homelessness incidence, healthcare cost savings through preventive measures, and the distributional impacts of public spending. Key Contributions: Scientific Director of the APPTA aging and technology hub. Co-founder of the IMPART research collaborative. Author of influential studies on Housing First programs, opioid prescribing patterns, and the fiscal benefits of guaranteed annual income policies. Advising & Grants: Supervises multiple MSc students and has collaborated on grants analyzing healthcare utilization in New Brunswick and Alberta. His work often intersects with policy-making, emphasizing actionable insights from quantitative research. Labs & Teams: Leads the Dutton Research Group, which uses mascot Odin the Saint Bernard to foster team cohesion. Active in interdisciplinary collaborations across public health, sociology, and economics.
Prof. Dr. Mirko Kremer is a Professor of Supply Chain Management at the Frankfurt School of Finance & Management since July 2014. Prior to this, he was an Assistant Professor at Pennsylvania State University (2008-2014) and held visiting roles at London Business School, Kellogg School of Management, and INSEAD. He earned a Ph.D. in Business Administration from the University of Mannheim (2008), with prior studies in Business Administration at Mannheim (1999-2003) and Economics at Ruhr-Universität Bochum (1997-1999). Research Focus: Micro-behavioral foundations of supply chains, inventory management, sales forecasting, and service systems. Editorial Roles: Department Editor for Production and Operations Management , Associate Editor for Operations Research . Teaching: Courses in Operations Management, Supply Chain Strategy, and quantitative decision modeling at Frankfurt School, INSEAD, London Business School, and Kellogg School of Management. Research Trends: His work bridges behavioral economics with supply chain operations, emphasizing how human decision-making (e.g., managerial biases, consumer behavior) impacts inventory systems, pricing strategies, and forecasting accuracy. Recent articles focus on diagnostic errors under congestion, strategic sourcing biases, and dynamic pricing experiments.
Dr. Ahmet Acar is an Associate Professor at the Department of Biological Sciences, Middle East Technical University (METU), Ankara, Turkey. He leads the Cancer Precision Medicine and Drug Resistance Laboratory, focusing on understanding mechanisms of drug resistance in cancer. His research integrates experimental models, next-generation sequencing, and deep learning to address clinical challenges in cancer therapy. Dr. Acar holds a B.Sc. from METU's Biological Sciences department and a Ph.D. from the Cancer Research UK Manchester Institute. He completed postdoctoral training at the Institute of Cancer Research, London, and the University of Manchester. Research Interests: Drug resistance mechanisms, precision oncology, tumor microenvironment modeling, patient-derived organoids, computational pathology, and evolutionary cancer biology. His lab develops 2D/3D co-culture systems, PDO biobanks, and AI-driven histopathology tools to improve treatment strategies. Recent Work Trends: Recent publications emphasize tumor evolution modeling, matrix mechanics in drug resistance, and AI applications in histopathology. Collaborations with hospitals in Turkey and Europe support PDO biobank initiatives. His team explores evolutionary steering strategies to exploit collateral drug sensitivities. Labs/Teams: Precision Medicine and Drug Resistance Lab at METU focuses on interdisciplinary approaches combining wet-lab experiments with computational methods. Current projects include ex vivo tumor modeling and AI-driven diagnostic tools for oncology.
Changhuei Yang is the Thomas G. Myers Professor of Electrical Engineering, Bioengineering, and Medical Engineering at California Institute of Technology, serving as Executive Officer for Electrical Engineering and Investigator at Heritage Medical Research Institute. He holds a Ph.D. and three master's degrees from MIT, with appointments at Caltech since 2003. Research focuses on: Advanced microscopy techniques including Fourier Ptychography Wavefront shaping for biological tissue imaging Optical phase conjugation for deep-tissue applications Compact medical devices for cerebral monitoring Publications demonstrate leadership in computational imaging, with recent advances in stain-free embryo analysis, portable cerebral blood flow monitors, and high-resolution volumetric imaging techniques using neural representations. Honored as National Academy of Inventors member. Research applications span deep-tissue biochemical imaging, incisionless surgery, and optogenetic activation systems.
Dr. Yunjie Yang is an Associate Professor at the University of Edinburgh's School of Engineering, with affiliations at the Edinburgh Futures Institute (EFI), the Edinburgh Generative AI Laboratory (GAIL), and the Edinburgh Centre for Robotics. He previously held the Chancellor's Fellow in Data Driven Innovation (2018-2023) and Bayes Innovation Fellow (2023-2024) positions. His research focuses on AI-powered sensing and imaging, machine learning, and soft sensors & electronics for robotics. Yang received his PhD in Engineering Electronics from the University of Edinburgh, MSc in Control Science & Engineering from Tsinghua University, and BEng in Measurement & Control Engineering from Anhui University. After his PhD, he worked as a Postdoctoral Research Associate in Chemical Species Tomography before securing his lectureship. His research interests center on developing intelligent sensing systems that replicate human perception capabilities for robotics and intelligent systems. He pioneers flexible sensing and imaging technologies across various scales through innovative multi-modal sensors, soft electronics, and their modeling using machine learning approaches. His work aims to enable autonomous physical artificial intelligence by bridging the gap between robotic systems and human-like perception. Analysis of his recent publications reveals a strong focus on soft robotics perception, particularly through electrical impedance tomography (EIT) and transformer-based architectures. His research spans medical imaging applications, digital twin modeling for industrial processes, and machine learning approaches for sensor data interpretation. The trend shows increasing integration of physics-informed deep learning with traditional tomographic techniques to achieve higher accuracy and efficiency. European Research Council (ERC) Starting Grant (2024) IEEE J. Barry Oakes Advancement Award (2024) IEEE I&M Society Graduate Fellowship Award (2015) Multiple Best Paper Awards Senior Member of IEEE Fellow of the International Society for Industrial Process Tomography Fellow of the Higher Education Academy ESI highly cited papers Dr. Yang serves as Associate Editor for IEEE Transactions on Instrumentation and Measurement and holds editorial positions with Scientific Reports and IEEE Sensors Journal. His research has been licensed to overseas research institutes and industry partners and received wide media coverage including BBC, EFE, USA Today, and STV. He has secured significant grant funding including the prestigious ERC Starting Grant. He leads the Edinburgh SMART Lab (Sensing/imaging + Machine Learning + Robotics), which aims to replicate human perception capabilities for robotics and advance flexible sensing technologies through innovative multi-modal sensors and machine learning approaches. The lab focuses on enabling autonomous physical artificial intelligence with applications spanning medical diagnostics, industrial monitoring, and advanced robotics systems.
Professor Matthias Mann is a world-leading scientist serving as Director of the Proteomics and Signal Transduction department at the Max Planck Institute of Biochemistry in Martinsried, Germany, and Director of the Proteomics department at the Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Denmark. With an h-index exceeding 277 and over 350,000 citations, he is recognized as the highest cited German researcher and one of the most influential scientists globally in proteomics. His educational background includes: Ph.D. in Chemical Engineering from Yale University (1988) Master's Degree in Physics from Georg August University Göttingen (1984) Bachelor's of Arts in Mathematics from Georg August University Göttingen (1982) Professor Mann's research focuses on advancing mass spectrometry-based proteomics to understand biological systems at the protein level. His work spans technological developments in mass spectrometry, bioinformatics and computational analysis, signal transduction and posttranslational modifications, and clinical proteomics applications for disease diagnosis and treatment. The Mann lab has pioneered groundbreaking methods like SILAC for quantitative proteomics and MaxQuant for proteome data analysis. Their vision is to translate proteomics knowledge into clinical practice for predictive, diagnostic, and preventive medicine, with recent work focusing on AI-guided platforms for analyzing proteomes from minimal tissue samples. Analysis of Professor Mann's recent publications reveals a strong trend toward clinical applications of proteomics, particularly in cancer research, metabolic diseases, and neurodegenerative disorders. His work increasingly integrates spatial proteomics, single-cell resolution techniques, and artificial intelligence approaches to uncover disease mechanisms and identify potential biomarkers, with a clear shift from basic technology development toward direct clinical applications and personalized medicine. Professor Mann has received numerous prestigious awards throughout his career: 2025: Elected member of the American National Academy of Sciences 2024: Dr. H.P. Heineken Award for Biochemistry and Biophysics 2023: Otto Warburg Medal 2019: Nominated member of the Bavarian Academy of Sciences 2013: Elected member of Leopoldina German National Academy of Sciences 2012: Körber European Science Award, Louis-Jeantet Foundation Prize for Medicine, Ernst Schering Prize, and Leibniz Prize Professor Mann leads a highly collaborative research team involved in multiple international networks including the Bill & Melinda Gates Foundation, Michael J. Fox Foundation for Parkinson's Research, CLINSPECT-M, and Munich Heart Alliance. His lab has mentored numerous successful researchers, with several former postdocs receiving prestigious ERC Starting Grants. The Mann group has developed innovative clinical proteomics pipelines for analyzing archived tissue specimens and body fluids, aiming to identify protein markers for early detection of diseases such as diabetes and cancer. The Mann lab operates across two major research centers with state-of-the-art mass spectrometry facilities. Their Clinical Knowledge Graph platform integrates multi-omics data with extensive metadata, creating an ecosystem for machine learning applications in proteomics. Current research focuses on developing highly sensitive methods that can profile thousands of proteins from minimal cell samples, enabling the identification of critical disease-related proteins and supporting the development of individualized therapies.
Dr. Paola Madini serves as Senior Lecturer in Accounting within the Department for Accounting and Finance at Kent Business School, University of Kent. Holding a PhD from Bocconi University and PGCHE from Kent, she specializes in management control systems with prior academic appointments at ESADE and SDA Bocconi School of Management. Education: PhD in Business Administration and Management (Accounting and Control specialization), Bocconi University PGCHE, University of Kent Fellow of the Higher Education Academy Her research examines management control systems (MCS) design and behavioral implications, focusing on budgeting processes, performance measurement, and inter-organizational relationships. Using field-based case studies and surveys with finance professionals, she bridges academic theory with practical applications in accounting management. Recent work investigates pandemic impacts on UK healthcare organizations' MCS and explores management accounting education through participative teaching methodologies and flipped learning approaches. Publication analysis reveals consistent contributions to management accounting literature, with recurring themes in MCS configurations (coercive, enabling, diagnostic, interactive), budgetary design, and industry-specific applications in fashion/retail sectors. Her work demonstrates evolving focus from traditional budgeting processes toward contemporary challenges like emerging market dividend policies and pandemic-driven organizational adaptations. Scientific Awards: Distinguished Reviewer Award 2017 (Journal of Management Control) Runner up reviewer 2015 (Journal of Management Control) She actively supervises postgraduate research including six Master's theses on managerial reporting systems in retail, fashion company accounting implementations, and neo-colonial accounting education frameworks. Industry collaborations include IBM Italy (integrative finance organizations), DocFlow (document management systems), and CIMA (fashion company accounting systems), with current projects examining pandemic impacts on UK healthcare management control systems. As member of the McGraw Hill Higher Education Advisory Board and conference committees (Socialising Business Research, AAA Annual Meeting), she contributes to academic community development while advising publishers on management accounting textbook development and portfolio strategies.
